C0268547||Argininosuccinic Acid Lyase Deficiency
C0027617||Newborn Screen
C0268547||Argininosuccinic acid lyase (ASL) deficiency
C0026882||mutations
C1412582||ASL gene
C0950133||OMIM: 608310
C0597619||urea cycle
C0012634||disorder
C2936488||pleiotropic presentations
C0268547||ASL deficiency
C1867987||neurocognitive abnormalities
C3714756||intellectual disability
C0751265||learning disabilities
C0012159||Dietary management
C0003765||arginine
C1261361||supplementation
C1457887||symptoms
C1457887||symptoms
C0268547||ASL deficiency
C0027617||newborn screening
C0041703||USA
C0684224||report
C0268547||ASL deficiency
C0027617||newborn screening
C0041703||USA
C3816499||pathogenic
C0026882||mutations
C0243095||no residual activity
C0243095||residual activity
C0027617||newborn screening
C0008864||citrulline
C0243095||findings
C0027617||newborn screening
C0268547||ASL deficiency
C0002085||hypomorphic allele
C0011900||diagnosed
C1457887||symptoms
C0268547||ASA deficiency
C2673720||protein aversion
C0424605||developmental delay
C0036572||seizures
C0268547||ASL deficiency
C1457887||nonspecific abnormal neurocognitive signs
C0014544||epilepsy
C0424605||developmental delay
C0027617||newborn screening